Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL1332 for Capsaicin-Induced Ocular Pain in Healthy Subjects
NCT07717918Phase 1Completed
- Sponsor
- Bausch + Lomb
- Start
- Jul 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing BL1332 eye drops with BL1332 Placebo eye drops (2 arms). Primary endpoint: Numeric Pain Rating Scale. Started Jul 2026; status: completed.
02
Drugs
BL1332
Beyond the preview
Go deeper on NCT07717918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717918.